retatrutide diabetes trial Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 Retatrutide Results: 28.3% Weight Loss

Liraglutide (Victoza, Saxenda): Also approved by the FDA for weight loss, but requires daily injections to see results

This effect was suggested to be due to multiple mechanisms, including alteration of the bile acid pool, changes in microbiota composition, improvement of hepatic glucose metabolism, and increased release of incretin hormones (204, 205)

HD, Huntingtons disease

Today, federal GLP-1 multidistrict litigation involving gastrointestinal injuries now includes thousands of pending cases, and a separate federal multidistrict litigation has been established for vision-loss claims involving non-arteritic anterior ischemic optic neuropathy (NAION)

When a protein shake replaces the slow preparation of a shared meal

To view or add a comment, sign in Dr